Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Danaher Corp

DHR

Danaher Corp

Danaher Corp historical holders

total: 15

Third Point Danaher Corp transactions over time

Total transactions:
31
New positions:
2
Sold out:
1
Added:
11
Reduced:
17
Held since:
2025 Q2
Held for:
5 quarters
Latest activity:
2026 Q2
Daniel Loeb has been an institutional investor in Danaher Corp (DHR) since 2015 Q3. According to 2026 Q2 report, Daniel Loeb holds 540,000 shares with a market value of roughly $102.86M representing 2.21% of their equity portfolio. The fund/company first acquired DHR in 2015 Q3, initially purchasing about 2.25M shares. Daniel Loeb later completely sold out the position and reinvested in DHR again in 2025 Q2. Since the initial investment, Third Point has made 30 more transactions in this position.

Does Daniel Loeb still hold DHR?

Yes, Daniel Loeb continues to hold Danaher Corp (DHR). According to their 2026 Q2 report, they maintain a position of 540,000 shares valued at approximately $102.86M, representing 2.21% of their equity portfolio.

When did Daniel Loeb first invest in DHR?

Daniel Loeb first invested in Danaher Corp (DHR) in 2015 Q3 at the reported quarter-end price of $85.21 per share, acquiring 2,250,000 shares in their initial purchase.

What is Daniel Loeb's average cost basis for DHR?

Based on historical transaction data, Daniel Loeb's estimated cost basis for Danaher Corp (DHR) is approximately $213.65 per share. This represents their average reported price* across all buy transactions.

Has Daniel Loeb reinvested in DHR after selling?

Yes, Daniel Loeb has shown renewed interest in Danaher Corp (DHR). After completely selling their position, they reinitiated an investment in 2025 Q2, demonstrating continued conviction in this ticker.

Estimated cost basis*

Weighted AVG buy price:
$213.65
Weighted AVG sell price:
$197.02

DHR transactions history by Third Point

31 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q2
2.21%
540,000
$190.48
$102,859,200
+2.86% (+15,000)
+0.06%
2026 Q1
4.78%
525,000
$189.60
$99,540,000
-12.50% (-75,000)
-0.2%
2025 Q4
1.89%
600,000
$228.92
$137,352,000
+1,100.00% (+550,000)
+1.73%
2025 Q3
0.12%
50,000
$198.26
$9,913,000
-90.00% (-450,000)
-1.17%
2025 Q2
1.30%
500,000
$197.54
$98,770,000
new
+1.3%
2025 Q1
0.00%
0
$229.55
-100% (-1,900,000)
-5.86%
2024 Q4
5.86%
1,900,000
$229.55
$436,145,000
-2.56% (-50,000)
-0.15%
2024 Q3
7.30%
1,950,000
$278.02
$542,139,000
-4.88% (-100,000)
-0.32%
2023 Q4
7.14%
2,050,000
$231.34
$474,247,000
-16.33% (-400,000)
-1.41%
2023 Q3
9.29%
2,450,000
$248.10
$607,845,000
-5.77% (-150,000)
-0.55%
2023 Q2
9.14%
$240.00
-5.45% (-150,000)
2023 Q1
11.34%
$252.04
+1.85% (+50,000)
2022 Q3
12.60%
$258.29
+17.39% (+400,000)
2022 Q2
13.80%
$253.52
-7.63% (-190,000)
2022 Q1
9.51%
$293.33
-14.14% (-410,000)
2021 Q4
6.66%
$329.01
+1.22% (+35,000)
2021 Q2
4.50%
$268.36
-1.21% (-35,000)
2021 Q1
4.40%
$225.08
-3.33% (-100,000)
2020 Q2
7.26%
$176.83
-15.97% (-570,000)
2020 Q1
7.89%
$138.41
-3.77% (-140,000)
2019 Q1
5.49%
$132.02
+19.29% (+600,000)
2018 Q4
4.93%
$103.12
-4.31% (-140,000)
2018 Q1
2.52%
$97.91
-1.81% (-60,000)
2017 Q4
2.28%
$92.82
+0.30% (+10,000)
2017 Q2
2.47%
$84.39
+6.45% (+200,000)
2017 Q1
2.61%
$85.53
-4.62% (-150,000)
2016 Q4
2.48%
$77.84
-27.78% (-1,250,000)
2016 Q3
3.07%
$78.39
+16.88% (+650,000)
2016 Q2
3.75%
$101.00
+4.05% (+150,000)
2016 Q1
3.29%
$94.86
+64.44% (+1,450,000)
2015 Q3
1.85%
$85.21
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.